54 related articles for article (PubMed ID: 22170006)
1. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.
Shukla N; Kobos R; Renaud T; Teruya-Feldstein J; Price A; McAllister-Lucas L; Steinherz P
Cancer; 2012 Aug; 118(15):3719-24. PubMed ID: 22170006
[TBL] [Abstract][Full Text] [Related]
2. Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification.
Takahashi E; Nakamura S
J Clin Exp Hematop; 2013; 53(1):1-8. PubMed ID: 23801128
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
Heath JL; Burgett SE; Gaca AM; Jaffe R; Wechsler DS
Pediatr Blood Cancer; 2014 Oct; 61(10):1874-6. PubMed ID: 24888336
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.
Dalia S; Jaglal M; Chervenick P; Cualing H; Sokol L
Cancers (Basel); 2014 Nov; 6(4):2275-95. PubMed ID: 25405526
[TBL] [Abstract][Full Text] [Related]
5. Trametinib in Histiocytic Sarcoma with an Activating MAP2K1 (MEK1) Mutation.
Gounder MM; Solit DB; Tap WD
N Engl J Med; 2018 May; 378(20):1945-1947. PubMed ID: 29768143
[No Abstract] [Full Text] [Related]
6. Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature.
Farris M; Hughes RT; Lamar Z; Soike MH; Menke JR; Ohgami RS; Winkfield K
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e1-e8. PubMed ID: 30396823
[TBL] [Abstract][Full Text] [Related]
7. Targeting MEK in a Translational Model of Histiocytic Sarcoma.
Takada M; Hix JML; Corner S; Schall PZ; Kiupel M; Yuzbasiyan-Gurkan V
Mol Cancer Ther; 2018 Nov; 17(11):2439-2450. PubMed ID: 30135215
[TBL] [Abstract][Full Text] [Related]
8. Favorable outcome of a histiocytic sarcoma patient treated with immune checkpoint inhibitor: a case report.
Nguyen LT; Pham GH; Vu PT; Yi HG
Ann Med Surg (Lond); 2023 Dec; 85(12):6274-6278. PubMed ID: 38098600
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
Geerlinks AV; Abla O
Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Incidental Histiocytic Sarcoma Concomitant with Laryngeal Carcinoma.
Oka S; Ono K; Nohgawa M
Intern Med; 2021 Aug; 60(16):2659-2662. PubMed ID: 33678749
[TBL] [Abstract][Full Text] [Related]
11. Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.
Bose S; Robles J; McCall CM; Lagoo AS; Wechsler DS; Schooler GR; Van Mater D
Pediatr Blood Cancer; 2019 Jan; 66(1):e27491. PubMed ID: 30270506
[No Abstract] [Full Text] [Related]
12. Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Voruz S; Cairoli A; Naveiras O; de Leval L; Missiaglia E; Homicsko K; Michielin O; Blum S
Haematologica; 2018 Jan; 103(1):e39-e41. PubMed ID: 29097496
[No Abstract] [Full Text] [Related]
13. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in histiocytic sarcoma identified by next generation sequencing.
Liu Q; Tomaszewicz K; Hutchinson L; Hornick JL; Woda B; Yu H
Virchows Arch; 2016 Aug; 469(2):233-41. PubMed ID: 27259537
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal Germ Cell Tumor-associated Histiocytic Proliferations Treated With Thalidomide Plus Chemotherapy Followed by Alemtuzumab-containing Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.
Fang LH; Shih LS; Lee PI; Chen WT; Chen RL
Medicine (Baltimore); 2016 Jan; 95(2):e2515. PubMed ID: 26765473
[TBL] [Abstract][Full Text] [Related]
16. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
